[Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial]. / Botulinicheskii toksin tipa A (Relatoks) v lechenii khronicheskoi migreni u vzroslykh: rezul'taty mul'titsentrovogo prostogo slepogo randomizirovannogo sravnitel'nogo issledovaniya IIIb fazy.
Zh Nevrol Psikhiatr Im S S Korsakova
; 123(5): 89-99, 2023.
Article
in Ru
| MEDLINE
| ID: mdl-37315247
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Botulinum Toxins, Type A
/
Acute Pain
/
Migraine Disorders
Type of study:
Clinical_trials
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Language:
Ru
Journal:
Zh Nevrol Psikhiatr Im S S Korsakova
Journal subject:
NEUROLOGIA
/
PSIQUIATRIA
Year:
2023
Document type:
Article
Affiliation country:
RUSSIA
Country of publication:
RUSSIA